145 related articles for article (PubMed ID: 37495265)
1. Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness.
Severin F; Mouawad N; Ruggeri E; Visentin A; Martinello L; Pagnin E; Trimarco V; Pravato S; Angotzi F; Facco M; Trentin L; Frezzato F
Br J Haematol; 2023 Oct; 203(2):224-236. PubMed ID: 37495265
[TBL] [Abstract][Full Text] [Related]
2. Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia.
ten Hacken E; Scielzo C; Bertilaccio MT; Scarfò L; Apollonio B; Barbaglio F; Stamatopoulos K; Ponzoni M; Ghia P; Caligaris-Cappio F
Blood; 2013 Mar; 121(12):2264-73. PubMed ID: 23325840
[TBL] [Abstract][Full Text] [Related]
3. Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells.
Martini V; Gattazzo C; Frezzato F; Trimarco V; Pizzi M; Chiodin G; Severin F; Scomazzon E; Guzzardo V; Saraggi D; Raggi F; Martinello L; Facco M; Visentin A; Piazza F; Brunati AM; Semenzato G; Trentin L
Br J Haematol; 2017 Jul; 178(1):81-93. PubMed ID: 28419476
[TBL] [Abstract][Full Text] [Related]
4. Integrin alpha2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway.
Sawhney RS; Cookson MM; Omar Y; Hauser J; Brattain MG
J Biol Chem; 2006 Mar; 281(13):8497-510. PubMed ID: 16461767
[TBL] [Abstract][Full Text] [Related]
5. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
6. Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia.
Gattazzo C; Martini V; Frezzato F; Trimarco V; Tibaldi E; Castelli M; Facco M; Zonta F; Brunati AM; Zambello R; Semenzato G; Trentin L
Haematologica; 2014 Jun; 99(6):1069-77. PubMed ID: 24532043
[TBL] [Abstract][Full Text] [Related]
7. B cell receptor signaling involves physical and functional association of FAK with Lyn and IgM.
Mlinaric-Rascan I; Yamamoto T
FEBS Lett; 2001 Jun; 498(1):26-31. PubMed ID: 11389892
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals.
McCaig AM; Cosimo E; Leach MT; Michie AM
Br J Haematol; 2011 Apr; 153(2):199-211. PubMed ID: 21352196
[TBL] [Abstract][Full Text] [Related]
9. Modulation of intracellular calcium levels by calcium lactate affects colon cancer cell motility through calcium-dependent calpain.
Sundaramoorthy P; Sim JJ; Jang YS; Mishra SK; Jeong KY; Mander P; Chul OB; Shim WS; Oh SH; Nam KY; Kim HM
PLoS One; 2015; 10(1):e0116984. PubMed ID: 25629974
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motility.
Wang W; Liu Y; Liao K
BMC Cell Biol; 2011 Nov; 12():49. PubMed ID: 22078467
[TBL] [Abstract][Full Text] [Related]
11. HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen.
Frezzato F; Gattazzo C; Martini V; Trimarco V; Teramo A; Carraro S; Cabrelle A; Ave E; Facco M; Zambello R; Tibaldi E; Brunati AM; Semenzato G; Trentin L
PLoS One; 2012; 7(6):e39902. PubMed ID: 22768161
[TBL] [Abstract][Full Text] [Related]
12. Cell invasion by Neisseria meningitidis requires a functional interplay between the focal adhesion kinase, Src and cortactin.
Slanina H; Hebling S; Hauck CR; Schubert-Unkmeir A
PLoS One; 2012; 7(6):e39613. PubMed ID: 22768099
[TBL] [Abstract][Full Text] [Related]
13. Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia.
Martini V; Frezzato F; Severin F; Raggi F; Trimarco V; Martinello L; Molfetta R; Visentin A; Facco M; Semenzato G; Paolini R; Trentin L
Oncotarget; 2018 Aug; 9(63):32219-32231. PubMed ID: 30181811
[TBL] [Abstract][Full Text] [Related]
14. T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
Damle RN; Temburni S; Banapour T; Paul S; Mongini PK; Allen SL; Kolitz JE; Rai KR; Chiorazzi N
Blood; 2012 Sep; 120(12):2438-49. PubMed ID: 22875913
[TBL] [Abstract][Full Text] [Related]
15. Cortactin as a target for FAK in the regulation of focal adhesion dynamics.
Tomar A; Lawson C; Ghassemian M; Schlaepfer DD
PLoS One; 2012; 7(8):e44041. PubMed ID: 22952866
[TBL] [Abstract][Full Text] [Related]
16. αB-crystallin interacts with and prevents stress-activated proteolysis of focal adhesion kinase by calpain in cardiomyocytes.
Pereira MB; Santos AM; Gonçalves DC; Cardoso AC; Consonni SR; Gozzo FC; Oliveira PS; Pereira AH; Figueiredo AR; Tiroli-Cepeda AO; Ramos CH; de Thomaz AA; Cesar CL; Franchini KG
Nat Commun; 2014 Oct; 5():5159. PubMed ID: 25319025
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
[TBL] [Abstract][Full Text] [Related]
18. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.
Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F
J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393
[TBL] [Abstract][Full Text] [Related]
19. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
20. PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic target.
Sbrana FV; Fiordi B; Bordini J; Belloni D; Barbaglio F; Russo L; Scarfò L; Ghia P; Scielzo C
J Cell Mol Med; 2023 Feb; 27(4):576-586. PubMed ID: 36747338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
